Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up
2007

Regional Radiotherapy as an Alternative to Axillary Lymph Node Dissection in Breast Cancer

Sample size: 521 publication Evidence: moderate

Author Information

Author(s): Patty H Spruit, Sabine Siesling, Marloes AG Elferink, Ernest JA Vonk, Carel JM Hoekstra

Primary Institution: Radiotherapeutic Institute RISO, Deventer, The Netherlands

Hypothesis

Can regional radiotherapy provide similar control rates and survival as axillary lymph node dissection while reducing morbidity in breast cancer patients aged 50 and older?

Conclusion

Regional recurrence rates after regional radiotherapy are very low and can safely replace surgery in a clinically negative axilla.

Supporting Evidence

  • The regional relapse rates were low and equal in both treatment groups, 1.1% in RT-group versus 1.5% in S-group at 5 years.
  • The overall survival was similar; the disease free survival was significantly better in the RT-group.
  • The median follow up was 7.2 years.

Takeaway

Instead of removing lymph nodes in breast cancer surgery, doctors can use radiation therapy, which is safer and has fewer side effects.

Methodology

The study compared outcomes of 180 women treated with regional radiotherapy to 341 women who underwent axillary lymph node dissection.

Potential Biases

Selection bias due to non-randomized design.

Limitations

The study is non-randomized, which may introduce selection bias.

Participant Demographics

Women aged 50 years and older with T1/T2 cN0 breast cancer.

Statistical Information

P-Value

0.003

Confidence Interval

0.3 – 0.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1748-717X-2-40

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication